Post-switching discontinuation of biosimilars in psoriasis: registry analyses fall short in addressing real-world biases. Puig L. Br J Dermatol 2025 Jan 7:ljaf003. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Puig L. Post-switching discontinuation of biosimilars in psoriasis: registry analyses fall short in addressing real-world biases. Br J Dermatol 2025 Jan 7:ljaf003. doi: 10.1093.
PMID: 39761694